Showing results (11-20 of 309) with videos related to
Sort By:
Pageof 31
British Heart Journal|January 1, 1986
Haemostatic function in myocardial infarctionA Hamsten, M Blombäck, B Wiman, et al.Journal of Internal Medicine|January 24, 2007
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentrationM N Mannila, P Eriksson, K Leander, et al.Thrombosis and Haemostasis|August 26, 1998
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass graftingE Moor, A Silveira, F van't Hooft, et al.Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.Thrombosis Research|March 9, 2000
Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closureE Moor, M Blombäck, A Silveira, et al.The Biochemical Journal|October 1, 1980
Affinity-chromatographic purification of human alpha 2-antiplasminB WimanCurrent Opinion in Hematology|September 1, 1996
Plasminogen activator inhibitor 1 in thrombotic diseaseB WimanThrombosis and Haemostasis|July 1, 1995
Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic diseaseB WimanEuropean Journal of Biochemistry|June 1, 1977
Primary structure of the B-chain of human plasminB WimanScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Predictive value of fibrinolytic factors in coronary heart diseaseB WimanPageof 31